Morillas Montserrat, López-Viñas Eduardo, Valencia Alfonso, Serra Dolors, Gómez-Puertas Paulino, Hegardt Fausto G, Asins Guillermina
Department of Biochemistry and Molecular Biology, School of Pharmacy, University of Barcelona, E-08028 Barcelona, Spain.
Biochem J. 2004 May 1;379(Pt 3):777-84. doi: 10.1042/BJ20031373.
CPT I (carnitine palmitoyltransferase I) catalyses the conversion of palmitoyl-CoA into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria. We propose a 3-D (three-dimensional) structural model for L-CPT I (liver CPT I), based on the similarity of this enzyme to the recently crystallized mouse carnitine acetyltransferase. The model includes 607 of the 773 amino acids of L-CPT I, and the positions of carnitine, CoA and the palmitoyl group were assigned by superposition and docking analysis. Functional analysis of this 3-D model included the mutagenesis of several amino acids in order to identify putative catalytic residues. Mutants D477A, D567A and E590D showed reduced L-CPT I activity. In addition, individual mutation of amino acids forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants T686A and S687A and altered K(m) and the catalytic efficiency for carnitine in mutant S685A. We conclude that the catalytic residues are His473 and Asp477, while Ser687 probably stabilizes the transition state. Several conserved lysines, i.e. Lys455, Lys505, Lys560 and Lys561, were also mutated. Only mutants K455A and K560A showed decreases in activity of 50%. The model rationalizes the finding of nine natural mutations in patients with hereditary L-CPT I deficiencies.
肉碱棕榈酰转移酶I(CPT I)在L-肉碱存在的情况下催化棕榈酰辅酶A转化为棕榈酰肉碱,促进脂肪酸进入线粒体。基于该酶与最近结晶的小鼠肉碱乙酰转移酶的相似性,我们提出了肝脏CPT I(L-CPT I)的三维(3-D)结构模型。该模型包含L-CPT I 773个氨基酸中的607个,通过叠加和对接分析确定了肉碱、辅酶A和棕榈酰基团的位置。对该三维模型的功能分析包括对几个氨基酸进行诱变,以确定可能的催化残基。突变体D477A、D567A和E590D的L-CPT I活性降低。此外,构成保守的Ser685-Thr686-Ser687基序的氨基酸的单个突变使突变体T686A和S687A的酶活性丧失,并改变了突变体S685A中肉碱的米氏常数(K(m))和催化效率。我们得出结论,催化残基是His473和Asp477,而Ser687可能稳定过渡态。几个保守的赖氨酸,即Lys455、Lys505、Lys560和Lys561也被诱变。只有突变体K455A和K560A的活性降低了50%。该模型解释了遗传性L-CPT I缺陷患者中九个自然突变的发现。